$SLXP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SALIX PHARMACEUTICALS LTD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in SALIX PHARMACEUTICALS LTD. Get notifications about new insider transactions in SALIX PHARMACEUTICALS LTD for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 8 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 106,000 | |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 107,000 | |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 108,000 | |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.85 | 100 | 1,085 | 108,371 | 108.5 K to 108.4 K (-0.09 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.88 | 100 | 1,088 | 108,471 | 108.6 K to 108.5 K (-0.09 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.94 | 100 | 1,094 | 108,571 | 108.7 K to 108.6 K (-0.09 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.95 | 100 | 1,095 | 108,671 | 108.8 K to 108.7 K (-0.09 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.96 | 100 | 1,096 | 108,771 | 108.9 K to 108.8 K (-0.09 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.97 | 100 | 1,097 | 108,871 | 109 K to 108.9 K (-0.09 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.98 | 200 | 2,196 | 108,971 | 109.2 K to 109 K (-0.18 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.00 | 200 | 2,200 | 109,171 | 109.4 K to 109.2 K (-0.18 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.43 | 283 | 2,952 | 108,371 | 108.7 K to 108.4 K (-0.26 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.48 | 317 | 3,322 | 108,654 | 109 K to 108.7 K (-0.29 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.52 | 200 | 2,104 | 108,971 | 109.2 K to 109 K (-0.18 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.63 | 200 | 2,126 | 109,171 | 109.4 K to 109.2 K (-0.18 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.55 | 200 | 2,110 | 108,371 | 108.6 K to 108.4 K (-0.18 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.56 | 100 | 1,056 | 108,571 | 108.7 K to 108.6 K (-0.09 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.57 | 200 | 2,114 | 108,671 | 108.9 K to 108.7 K (-0.18 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.59 | 100 | 1,059 | 108,871 | 109 K to 108.9 K (-0.09 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.61 | 100 | 1,061 | 108,971 | 109.1 K to 109 K (-0.09 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.62 | 100 | 1,062 | 109,071 | 109.2 K to 109.1 K (-0.09 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.64 | 100 | 1,064 | 109,171 | 109.3 K to 109.2 K (-0.09 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.66 | 100 | 1,066 | 109,271 | 109.4 K to 109.3 K (-0.09 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 109,000 | |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 110,000 | |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 111,000 | |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.97 | 300 | 2,991 | 108,371 | 108.7 K to 108.4 K (-0.28 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.98 | 500 | 4,990 | 108,671 | 109.2 K to 108.7 K (-0.46 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.05 | 100 | 1,005 | 109,171 | 109.3 K to 109.2 K (-0.09 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.06 | 100 | 1,006 | 109,271 | 109.4 K to 109.3 K (-0.09 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.68 | 249 | 2,410 | 108,371 | 108.6 K to 108.4 K (-0.23 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.69 | 100 | 969 | 108,620 | 108.7 K to 108.6 K (-0.09 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.70 | 51 | 495 | 108,720 | 108.8 K to 108.7 K (-0.05 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.71 | 173 | 1,680 | 108,771 | 108.9 K to 108.8 K (-0.16 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.73 | 100 | 973 | 108,944 | 109 K to 108.9 K (-0.09 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.75 | 100 | 975 | 109,044 | 109.1 K to 109 K (-0.09 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.76 | 100 | 976 | 109,144 | 109.2 K to 109.1 K (-0.09 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.78 | 100 | 978 | 109,244 | 109.3 K to 109.2 K (-0.09 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.79 | 2 | 20 | 109,344 | 109.3 K to 109.3 K (0.00 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.81 | 25 | 245 | 109,346 | 109.4 K to 109.3 K (-0.02 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.86 | 100 | 986 | 108,371 | 108.5 K to 108.4 K (-0.09 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.90 | 500 | 4,950 | 108,471 | 109 K to 108.5 K (-0.46 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.93 | 100 | 993 | 108,971 | 109.1 K to 109 K (-0.09 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.95 | 300 | 2,985 | 109,071 | 109.4 K to 109.1 K (-0.27 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 112,000 | |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 113,000 | |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 114,000 | |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.76 | 200 | 1,952 | 108,371 | 108.6 K to 108.4 K (-0.18 %) |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.79 | 500 | 4,895 | 108,571 | 109.1 K to 108.6 K (-0.46 %) |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.83 | 103 | 1,012 | 109,071 | 109.2 K to 109.1 K (-0.09 %) |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.84 | 97 | 954 | 109,174 | 109.3 K to 109.2 K (-0.09 %) |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.85 | 100 | 985 | 109,271 | 109.4 K to 109.3 K (-0.09 %) |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.83 | 100 | 983 | 108,371 | 108.5 K to 108.4 K (-0.09 %) |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.84 | 400 | 3,936 | 108,471 | 108.9 K to 108.5 K (-0.37 %) |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.86 | 400 | 3,944 | 108,871 | 109.3 K to 108.9 K (-0.37 %) |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.87 | 100 | 987 | 109,271 | 109.4 K to 109.3 K (-0.09 %) |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.76 | 100 | 976 | 108,371 | 108.5 K to 108.4 K (-0.09 %) |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.77 | 600 | 5,862 | 108,471 | 109.1 K to 108.5 K (-0.55 %) |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.78 | 300 | 2,934 | 109,071 | 109.4 K to 109.1 K (-0.27 %) |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 115,000 | |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 116,000 | |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.37 | 100 | 937 | 108,371 | 108.5 K to 108.4 K (-0.09 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.39 | 200 | 1,878 | 108,471 | 108.7 K to 108.5 K (-0.18 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.47 | 200 | 1,894 | 108,671 | 108.9 K to 108.7 K (-0.18 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.48 | 100 | 948 | 108,871 | 109 K to 108.9 K (-0.09 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.55 | 200 | 1,910 | 108,971 | 109.2 K to 109 K (-0.18 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.57 | 200 | 1,914 | 109,171 | 109.4 K to 109.2 K (-0.18 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.71 | 100 | 971 | 108,371 | 108.5 K to 108.4 K (-0.09 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.73 | 300 | 2,919 | 108,471 | 108.8 K to 108.5 K (-0.28 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.76 | 200 | 1,952 | 108,771 | 109 K to 108.8 K (-0.18 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.78 | 100 | 978 | 108,971 | 109.1 K to 109 K (-0.09 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.80 | 200 | 1,960 | 109,071 | 109.3 K to 109.1 K (-0.18 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.81 | 100 | 981 | 109,271 | 109.4 K to 109.3 K (-0.09 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Grant | A | 0.00 | 31,010 | 0 | 108,371 | 77.4 K to 108.4 K (+40.08 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Payment of Exercise | F | 9.87 | 6,028 | 59,496 | 77,361 | 83.4 K to 77.4 K (-7.23 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | Forbes William P | V.P. Research& Deve ... | Grant | A | 0.00 | 21,890 | 0 | 67,762 | 45.9 K to 67.8 K (+47.72 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | Forbes William P | V.P. Research& Deve ... | Payment of Exercise | F | 9.87 | 5,141 | 50,742 | 45,872 | 51 K to 45.9 K (-10.08 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | Sirgo Mark A | Director | Grant | A | 0.00 | 12,160 | 0 | 35,356 | 23.2 K to 35.4 K (+52.42 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | Sirgo Mark A | Director | Payment of Exercise | F | 9.87 | 3,930 | 38,789 | 23,196 | 27.1 K to 23.2 K (-14.49 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | Reeth Mark D | Gen Counsel&VP Corp ... | Grant | A | 0.00 | 18,240 | 0 | 51,939 | 33.7 K to 51.9 K (+54.13 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | Reeth Mark D | Gen Counsel&VP Corp ... | Payment of Exercise | F | 9.87 | 2,056 | 20,293 | 33,699 | 35.8 K to 33.7 K (-5.75 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Grant | A | 0.00 | 94,220 | 0 | 630,581 | 536.4 K to 630.6 K (+17.57 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Payment of Exercise | F | 9.87 | 22,086 | 217,989 | 536,361 | 558.4 K to 536.4 K (-3.95 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Grant | A | 0.00 | 12,160 | 0 | 64,360 | 52.2 K to 64.4 K (+23.30 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Payment of Exercise | F | 9.87 | 3,169 | 31,278 | 52,200 | 55.4 K to 52.2 K (-5.72 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | FRANCO RICHARD A | Director | Grant | A | 0.00 | 12,160 | 0 | 59,444 | 47.3 K to 59.4 K (+25.72 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | FRANCO RICHARD A | Director | Payment of Exercise | F | 9.87 | 3,930 | 38,789 | 47,284 | 51.2 K to 47.3 K (-7.67 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | CHAPPELL JOHN F | Director | Grant | A | 0.00 | 12,160 | 0 | 544,120 | 532 K to 544.1 K (+2.29 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | KEANE WILLIAM P | Director | Grant | A | 0.00 | 12,160 | 0 | 39,073 | 26.9 K to 39.1 K (+45.18 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | KEANE WILLIAM P | Director | Payment of Exercise | F | 9.87 | 4,355 | 42,984 | 26,913 | 31.3 K to 26.9 K (-13.93 %) |
Jul 02 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 117,000 | |
Jul 02 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.98 | 100 | 998 | 83,389 | 83.5 K to 83.4 K (-0.12 %) |
Jul 02 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.99 | 101 | 1,009 | 83,489 | 83.6 K to 83.5 K (-0.12 %) |
Jul 02 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.00 | 200 | 2,000 | 83,590 | 83.8 K to 83.6 K (-0.24 %) |
Jul 02 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.01 | 99 | 991 | 83,790 | 83.9 K to 83.8 K (-0.12 %) |
Jul 02 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.03 | 300 | 3,009 | 83,889 | 84.2 K to 83.9 K (-0.36 %) |
Jul 02 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.04 | 100 | 1,004 | 84,189 | 84.3 K to 84.2 K (-0.12 %) |
Jul 02 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.08 | 100 | 1,008 | 84,289 | 84.4 K to 84.3 K (-0.12 %) |
Jul 02 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 84,389 | 83.4 K to 84.4 K (+1.20 %) |
Jun 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 118,000 | |
Jun 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 119,000 | |
Jun 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 120,000 | |
Jun 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.99 | 21 | 210 | 83,389 | 83.4 K to 83.4 K (-0.03 %) |
Jun 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.00 | 79 | 790 | 83,410 | 83.5 K to 83.4 K (-0.09 %) |
Jun 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.01 | 200 | 2,002 | 83,489 | 83.7 K to 83.5 K (-0.24 %) |
Jun 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.03 | 1 | 10 | 83,689 | 83.7 K to 83.7 K (0.00 %) |
Jun 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.06 | 200 | 2,012 | 83,690 | 83.9 K to 83.7 K (-0.24 %) |
Jun 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.07 | 99 | 997 | 83,890 | 84 K to 83.9 K (-0.12 %) |
Jun 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.08 | 200 | 2,016 | 83,989 | 84.2 K to 84 K (-0.24 %) |
Jun 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.13 | 200 | 2,026 | 84,189 | 84.4 K to 84.2 K (-0.24 %) |
Jun 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 84,389 | 83.4 K to 84.4 K (+1.20 %) |
Jun 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.11 | 100 | 1,011 | 83,389 | 83.5 K to 83.4 K (-0.12 %) |
Jun 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.12 | 300 | 3,036 | 83,489 | 83.8 K to 83.5 K (-0.36 %) |
Jun 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.13 | 300 | 3,039 | 83,789 | 84.1 K to 83.8 K (-0.36 %) |
Jun 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.16 | 200 | 2,032 | 84,089 | 84.3 K to 84.1 K (-0.24 %) |
Jun 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.17 | 100 | 1,017 | 84,289 | 84.4 K to 84.3 K (-0.12 %) |
Jun 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 84,389 | 83.4 K to 84.4 K (+1.20 %) |
Jun 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.67 | 100 | 967 | 83,389 | 83.5 K to 83.4 K (-0.12 %) |
Jun 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.70 | 100 | 970 | 83,489 | 83.6 K to 83.5 K (-0.12 %) |
Jun 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.72 | 100 | 972 | 83,589 | 83.7 K to 83.6 K (-0.12 %) |
Jun 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.73 | 200 | 1,946 | 83,689 | 83.9 K to 83.7 K (-0.24 %) |
Jun 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.74 | 400 | 3,896 | 83,889 | 84.3 K to 83.9 K (-0.47 %) |
Jun 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.78 | 100 | 978 | 84,289 | 84.4 K to 84.3 K (-0.12 %) |
Jun 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 84,389 | 83.4 K to 84.4 K (+1.20 %) |
Jun 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 121,000 | |
Jun 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 122,000 | |
Jun 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 123,000 | |
Jun 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.68 | 197 | 1,907 | 83,389 | 83.6 K to 83.4 K (-0.24 %) |
Jun 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.70 | 303 | 2,939 | 83,586 | 83.9 K to 83.6 K (-0.36 %) |
Jun 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.74 | 200 | 1,948 | 83,889 | 84.1 K to 83.9 K (-0.24 %) |
Jun 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.75 | 100 | 975 | 84,089 | 84.2 K to 84.1 K (-0.12 %) |
Jun 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.79 | 200 | 1,958 | 84,189 | 84.4 K to 84.2 K (-0.24 %) |
Jun 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 84,389 | 83.4 K to 84.4 K (+1.20 %) |
Jun 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.82 | 200 | 1,964 | 83,389 | 83.6 K to 83.4 K (-0.24 %) |
Jun 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.83 | 400 | 3,932 | 83,589 | 84 K to 83.6 K (-0.48 %) |
Jun 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.85 | 100 | 985 | 83,989 | 84.1 K to 84 K (-0.12 %) |
Jun 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.89 | 200 | 1,978 | 84,089 | 84.3 K to 84.1 K (-0.24 %) |
Jun 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.91 | 100 | 991 | 84,289 | 84.4 K to 84.3 K (-0.12 %) |
Jun 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 84,389 | 83.4 K to 84.4 K (+1.20 %) |